- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03951090
Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer Patients
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This study evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in non-electively hospitalized older (> 70 years) adults with cancer. Participants will be randomly assigned to the GARRT group, or the control group. All participants will fill out user friendly questionnaire called the geriatric assessment. The results of the geriatric assessment will be given to the physicians of participants in the GARRT group in real-time. The physicians of participants in the control group will not receive real time results.
This study will compare the referral rates of participants in each group to determine if providing real-time results of the geriatric assessment impact referral rates.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
North Carolina
-
Chapel Hill, North Carolina, Forenede Stater, 27599
- UNC Lineberger Comprehensive Cancer Center
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Age 70 years or older.
- English speaking.
- Admitted to UNC Hospitals non-electively within 72 hours.
- Biopsy proven solid tumor or myeloma or lymphoma.
- Newly diagnosed cancer patients for whom active cancer directed therapy is planned within the next six months or patients on active cancer directed therapy either currently or within the previous 6 months.
- Signed written IRB-approved informed consent.
Exclusion Criteria:
- Patients meeting any of the following exclusion criteria at baseline will be excluded from study participation. Patients with a life expectancy <6 weeks
- Patients who are <48 hours post-surgery.
- Patients who are admitted to an intensive care setting.
- Patients with acute myeloma lymphoma (AML) or other high grade hematologic malignancies.
- Patients undergoing bone marrow transplant or admitted to the bone marrow transplant unit.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: GARRT Arm
Participants in this arm complete an brief geriatric assessment, and the results of these assessments are given to providers with recommendations to address deficits identified by the geriatric assessment
|
Providers will receive results of the brief geriatric assessment with recommendations for address deficits identified through the results of the brief geriatric assessment
|
|
Aktiv komparator: Control Arm
Providers of participants of this group will not receive the results of the brief geriatric assessments.
These participants will receive standard of care treatment
|
Providers will not receive results of the brief geriatric assessment.
Participants will receive standard of care treatment
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Referral rate for GA-identified deficits in intervention and control groups
Tidsramme: 2 years
|
Number of participants with at least one referral for a GA-idenfied deficit
|
2 years
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Referral to Physical and Occupational therapy
Tidsramme: 2 years
|
Number of times physical and occupation therapy referral was given in Intervention and Control group
|
2 years
|
|
Referral to Geriatic Consultation
Tidsramme: 2 years
|
Number of times a Geriatric Consultation referral was given in Intervention and Control group
|
2 years
|
|
Referral to Clinical Pharmacist
Tidsramme: 2 years
|
Number of times Clinical Pharmacist referral was given in Intervention and Control group
|
2 years
|
|
Referral to Nutritionist
Tidsramme: 2 years
|
Number of times Nutritionist referral was given in Intervention and Control group
|
2 years
|
|
Referral to psyhcosocial support team
Tidsramme: 2 years
|
Number of times psychosocial support referral was given in Intervention and Control group
|
2 years
|
|
Physician Reported New information
Tidsramme: 2 years
|
Number of times physicians answer "yes" to the questions "did report provide new information about patient deficits that would warrant a referral"
|
2 years
|
|
Physician Reported Satisfaction
Tidsramme: 2 years
|
Number of times physician indicate "yes" report was helpful when asked "Is this report useful"
|
2 years
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Trevor Jolly, MBBS, UNC Lineberger Comprehensive Cancer Center
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- LCCC 1538
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .